Every pharmaceutical company wants to score a perfect “Ten” when it comes to developing a new drug that relieves symptoms of an illness or mental malfunctions.
It looks like the German pharmaceutical company Boehringer Ingelheim is on the verge of getting a perfect score in the female sexual dysfunction arena.
The drug Flibanserin was originally designed to treat depression, but early tests on Flibanserin users indicated that women experienced more sexual desires and enjoyed more sexually satisfying encounters while using Flibanserin; that was the impetus Boehringer needed to clinical test Flibanserin as a female libido enhancer.
Sildenafil better known as Viagra went through the same process back in the 1990s when Pfizer thought Sildenafil was a hypertension medication, but discovered it could increase blood flow to the small blood vessel in the penis. Viagra is now the best selling prescription drug in the world.
Boehringer conducted four clinical tests and one of those tests included two thousand pre-menopausal women. Half took a placebo and the other half took 100mg of Flibanserin once a day for twenty-four weeks.
The women taking Flibanserin went from three sexual satisfying experiences a month to five a month, while the women taking a placebo didn’t experience a change in sexual desires. Boehringer continued testing women around the world and based on the data compiled in those test Boehringer expects the FDA to approve Flibanserin as a treatment for FSD symptoms.
When the FDA approves Flibanserin for prescription use most sexual researchers believe Flibanserin marketed under the brand name of Girosa or Ectris could match Viagra sales and may even exceed them due to the number of women around the world that live with some type of female sexual dysfunction.
Boehringer Used Two Non-Hormonal Agents to Produce Flibanserin
Flibanserin contains dopamine D4 receptor and 5-HT serotonin receptor. Flibanserin increases dopamine and noradrenaline and decreases serotonin in the brain.
No one knows why Flibanserin increases sexual desires and fantasies, but Boehringer researchers believe that combination has an impact on the central nervous system and that triggers sexual hormone production, which in turn increases the libido and sexual activity.
Most prescription medications contain synthetic hormones which can cause nasty side effects as well as negative mood swings. Boehringer says the clinical results show that Flibanserin does create some side effects like headaches, nausea, insomnia, dizziness, anxiety, and fatigue, but most women in the clinical studies overlook those side effects.